- Home
- PODD vs QXO Comparison
PODD vs QXO Comparison
Compare PODD & QXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PODD | QXO |
|---|---|---|
| Founded | 2000 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.2B | 11.3B |
| IPO Year | 2007 | 2014 |
Fundamental Metrics
Financial Performance| Metric | PODD | QXO |
|---|---|---|
| Price | $148.63 | $10.46 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 26 | 19 |
| Target Price | ★ $167.17 | $24.28 |
| AVG Volume (30 Days) | 1.3M | ★ 21.4M |
| Earning Date | 11-04-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 2.67 | N/A |
| Revenue | ★ $2,708,100,000.00 | $54,516,941.00 |
| Revenue This Year | $21.37 | $105.18 |
| Revenue Next Year | $13.57 | $32.41 |
| P/E Ratio | $55.86 | ★ N/A |
| Revenue Growth | ★ 30.73 | 21.19 |
| 52 Week Low | $126.40 | $10.04 |
| 52 Week High | $354.88 | $27.61 |
Technical Indicators
Market Signals| Indicator | PODD | QXO |
|---|---|---|
| Relative Strength Index (RSI) | 63.37 | 42.19 |
| Support Level | $139.67 | $10.04 |
| Resistance Level | $153.33 | $11.31 |
| Average True Range (ATR) | 4.18 | 0.61 |
| MACD | 1.71 | 0.03 |
| Stochastic Oscillator | 84.48 | 28.91 |
Price Performance
Historical ComparisonAbout PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, more than 600,000 insulin-dependent diabetic patients are using it worldwide.
About QXO QXO Inc.
QXO Inc is a publicly traded distributor of building products in North America. The company is executing its plan to become the tech-enabled leader in the around $800 billion building products distribution industry and generate outsized value for its shareholders. The group expects to achieve its target of nearly $50 billion in annual revenues within the next decade through accretive acquisitions and organic growth.